Cystoid macular edema (CME) is a condition characterized by the accumulation of fluid in the macula, leading to swelling and potential vision impairment. This condition can occur as a side effect ...

[45] *Included patients with macular edema due to various etiologies, including diabetes. NA = Not available. Stephen G. Schwartz, Bascom Palmer Eye Institute, University of Miami Miller School of ...

Seven months after the FDA signed off on a reintroduction of Roche’s eye implant Susvimo, the U.S. regulator has broadened its label as a treatment for diabetic macular edema (DME), which is the ...

Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing sustained vision improvements with fewer treatments than standard eye ...

VERONA is a phase II trial evaluating the company's lead investigational product Duravyu in diabetic macular edema patients previously treated with a standard-of-care FDA-approved anti-VEGF ...